Free Trial

Oruka Therapeutics (ORKA) SEC Filings & 10K Form

Oruka Therapeutics logo
$11.19 +0.61 (+5.77%)
Closing price 04:00 PM Eastern
Extended Trading
$11.20 +0.01 (+0.09%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Oruka Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
7:00 AM
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G
03/11/2025
11:15 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form EFFECT
03/10/2025
6:00 PM
Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SCHEDULE 13D/A
03/06/2025
4:17 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form POS AM
02/27/2025
5:42 PM
Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
5:42 PM
Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:43 PM
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/05/2025
3:00 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:44 PM
Agarwal Arjun (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:41 PM
Klein Lawrence Otto (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:42 PM
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Quinlan Paul T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:43 PM
Goncalves Joana (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
6:16 AM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
11:15 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form EFFECT
11/21/2024
5:30 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:30 PM
Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
11/14/2024
6:38 PM
Avidity Partners Management LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:49 PM
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:20 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2024
3:56 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:04 AM
Allostery Investments LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:56 AM
JANUS HENDERSON GROUP PLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
5:37 AM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/13/2024
3:01 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
3:15 PM
Adage Capital Management, L.P. (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
10/18/2024
3:11 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form DEF 14A
10/07/2024
10:37 AM
FMR LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G
10/04/2024
3:05 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:55 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:57 PM
Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
09/06/2024
4:00 PM
Klein Lawrence Otto (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:01 PM
Agarwal Arjun (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:02 PM
Goncalves Joana (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:03 PM
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Quinlan Paul T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:04 PM
BALL KRISTINE M (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:05 PM
Dambkowski Carl (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:06 PM
Kulkarni Samarth (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:07 PM
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Turtle Cameron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:07 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest III L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2024
4:08 PM
Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D
09/05/2024
4:18 PM
Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

08/30/2024
4:57 PM
ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Ma-Weaver Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
6:51 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
6:53 PM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/23/2024
3:35 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
1:23 PM
ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
3:25 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:27 PM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/15/2024
3:15 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:17 PM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/09/2024
7:35 AM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
08/01/2024
3:30 PM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
07/26/2024
9:50 AM
ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
11:15 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form EFFECT
07/24/2024
3:49 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form ARS
07/22/2024
4:17 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-4/A
07/12/2024
6:38 PM
ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
6:10 PM
ARCA biopharma, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Janus Henderson Biotech Innovation Master Fund Ltd (Reporting)
JANUS HENDERSON GROUP PLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2024
4:29 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-4/A
07/09/2024
4:01 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:04 PM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
07/05/2024
4:20 PM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
06/18/2024
4:17 PM
ARCA biopharma, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-4/A
06/06/2024
3:45 PM
ARCA biopharma, Inc. (Subject)
Oruka Therapeutics (Subject)
Form 425
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ORKA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners